Alexander B Sibley Selected Research

Neoplasms (Cancer)

11/2023	High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer.
1/2022	Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
10/2020	Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence.
10/2020	Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib.
11/2018	Genetic variation determines VEGF-A plasma levels in cancer patients.
1/2018	The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
12/2015	Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.
3/2015	Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander B Sibley Research Topics

Disease

8	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 03/2015
8	Neoplasms (Cancer) 11/2023 - 03/2015
5	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 01/2018
2	Hypertension (High Blood Pressure) 01/2022 - 01/2022
2	Proteinuria 01/2022 - 01/2022
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2016
2	Breast Neoplasms (Breast Cancer) 10/2020 - 05/2019
2	Leukemia 01/2018 - 12/2015
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Lymphoma (Lymphomas) 01/2021
1	Residual Neoplasm 10/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 11/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2019
1	Neutropenia 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2015

Drug/Important Bio-Agent (IBA)

8	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2016
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2015
5	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2016
4	Cetuximab (Erbitux)FDA Link 01/2022 - 03/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 11/2018
2	Long Noncoding RNAIBA 05/2024 - 12/2023
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 10/2016
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Abiraterone AcetateIBA 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	LuciferasesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	regorafenibIBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	MethylcholanthreneIBA 11/2019
1	CarcinogensIBA 11/2019
1	taxaneIBA 05/2019
1	Gemcitabine FDA Link 01/2019
1	Angiogenic ProteinsIBA 11/2018
1	LigandsIBA 11/2018
1	Vascular Endothelial Growth Factor CIBA 11/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 10/2016
1	Formaldehyde (Formol)FDA Link 03/2015
1	ParaffinIBA 03/2015
1	Messenger RNA (mRNA)IBA 03/2015

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 05/2024 - 03/2015
2	Therapeutics 10/2020 - 01/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 11/2023
1	Castration 01/2021
1	Homologous Transplantation 12/2015